Author: Dena Battle

New first line standard of care treatment for Stage 4 RCC

New data from the pivotal phase 3 Checkmate 214 trial combining ipilumimab and nivolumab presented at the European Society of Medical Oncology (ESMO) conference in Madrid showed superiority for the combination over Sunitinib (Sutent). The combination of nivolumab (Opdivo) and ipilimumab (Yervoy) was more effective in prolonging the lives of newly diagnosed metastatic renal cell carcinoma patients ...

KCCure Awards Inaugural Grant of $100,000 to Dana Farber for work in CAR T-Cell Research

WASHINGTON – The Kidney Cancer Research Alliance (KCCure) announced today that their first research grant of $100,000 has been awarded to Dr. Wayne Marasco, at Dana Farber Cancer Center for his proposal: CAR T-Cell Factories that change the Tumor Microenvironment to Achieve RCC Cures. “I am incredibly grateful to receive this award.  These funds will help support our translational program to...

Show your colors for World Kidney Cancer Day by helping us fund more research!

Are we green or orange?? That’s a question we get quite often when it comes to kidney cancer.  The answer is YES. And we are black and white.  We are democrats and republicans.  We are American, German, Mexican, Brazilian, South Korean.  Kidney cancer doesn’t discriminate.  We might not agree on everything – even the color of our ribbon – but we all agree that we want a cure for kidney...

June 22 is World Kidney Cancer Day!

As members of the International Kidney Cancer Coalition (IKCC), KCCure is a proud partner and participant of the first-ever World Kidney Cancer Q&A Day.  On June 22, 2017, patients, caregivers, health care professionals and local organizations from around the world will join together to raise awareness about kidney cancer. Why have World Kidney Cancer Q&A Day? Kidney cancer is a serious di...

Take our Survey and help us improve surveillance in Kidney Cancer

This year, 60,000 Americans will be diagnosed with kidney cancer.  Many of these cancers will be found incidentally – almost by accident.  Many patients are completely unprepared and don’t know what questions to ask or what kind of follow-up they should receive after their diagnosis.  While multiple guidelines exist, there isn’t a single uniform or standard plan for patients.  In...

KCCure Co-founder Susan Poteat presents to IKCC in Poland

As a nuclear physicist, co-founder Susan Poteat is not only a great asset to KCCure, she's also an amazing resource to the global patient community.

Voices of Kidney Cancer – Ken’s story

Thanks Ken for sharing your story about why it's so important to have regular follow-up care after a kidney cancer diagnosis!

Voices of Kidney Cancer – Laura’s story

My doctors and the researchers running clinical trials are my heroes. They are why I'm able to continue living my life, raising my children and enjoying time with my husband, family and friends.

Voices of Kidney Cancer – Holly and Joe

Does this story sound familiar? The ups and downs of a cancer diagnosis. Thank you Holly and Joe for sharing your story!

Still Always Yes

This photo of my daughter was taken eight years ago, a week before my husband was diagnosed with kidney cancer. Even though we didn't find a cure, I'm grateful for the past and hopeful for the future.

Voices of Kidney Cancer – Jennifer Leiser

My unique combination makes me a lab rat for my oncologists, and that's okay— I hope that my story will help everyone impacted by Tuberous Sclerosis Complex and Renal Cell Carcinoma.

Voices of Kidney Cancer – Elise Whitehill

Here’s to the caregivers who fight tirelessly for their loved ones battling kidney cancer.  The men and women who manage medication, drive to appointments, fax medical records and know more about their loved-ones illness than most doctors.  They monitor side effects better than a trial nurse.  And when necessary, they shave heads.  Thank you caregivers.  Thank you Elise, caregiver to Mark. N...

Lost Password

Register

Subscribe for updates!